Angus McLean > Simmons & Simmons > London, England > Lawyer Profile

With a solid bench strength possessing expertise across the technical and scientific arenas, Simmons & Simmons is well-positioned to undertake complex and global mandates for clients operating within the life sciences, fintech, and technology sectors. European Patent Attorney Kevin Cordina leads the group with his expertise in electronics and medical devices, and Michael Gavey is well-versed in transactional mandates. On the litigation side, Michael Burdon is noted for his strategic capabilities and Scott Parker routinely acts for pharmaceutical and biotech companies. Angus McLean co-leads the firm’s Emerging Technology Group, and Andrew Hutchinson covers a diverse range of patent litigation and regulatory issues. Further strengthening the practice is Priya Nagpal, who enjoys a wealth of experience across technologies such as medical devices and software, and she also possesses expertise in big data issues.

Strategic investments, commercial outsourcing transactions, and the drafting and negotiating of sales contracts with tier 1 banks are among the practice strengths at Simmons & Simmons. The emerging technology group is known for its expertise in areas such as AI, digital assets, tokenisation, disruptive litigation and payments. Co-head Angus McLean has a proven track record of advising on M&A deals and investments with a significant IP dimension. He is additionally well placed to act as product counsel for fintechs exploring new products and services. Fellow co-head Frances Doherty excels in transactional work connected to emerging technologies. Completing the leadership team, Sophie Sheldon frequently handles regulated outsourcing mandates. Tom Wales‘ wide-ranging focus encompasses commercialisation and collaboration agreements and strategic partnership transactions.